newsfilter
← Latest News
GlobeNewswire·

Purple Biotech Reports Second Quarter 2026 Financial Results

New preclinical data presented at European Association for Cancer Research (EACR) 2026 Annual Congress, which further validates the differentiated profile of IM1240's anti-tumor activity, favorable safety and